Controversies in the Management of Ischemic Cerebrovascular Accidents in Patients With Non-Promyelocytic Acute Myeloid Leukemia

Affiliations

Rodrick Babakhanlou et al. J Hematol. 2024 Oct.

. 2024 Oct;13(5):259-260.

doi: 10.14740/jh1342. Epub 2024 Oct 21.

¹ Division of Hematology and Oncology, The University of Arizona Cancer Center, Tucson, AZ, USA.

No abstract available

Conflict of interest statement

None to declare.

1. Babakhanlou R, DiNardo C, Borthakur G. IDH2 mutations in acute myeloid leukemia. Leuk Lymphoma. 2023;64(11):1733–1741. doi: 10.1080/10428194.2023.2237153. - DOI - PubMed
1. Babakhanlou R, Ravandi-Kashani F. Non-intensive acute myeloid leukemia therapies for older patients. Expert Rev Hematol. 2023;16(3):171–180. doi: 10.1080/17474086.2023.2184342. - DOI - PubMed
1. Giammarco S, Chiusolo P, Piccirillo N, Di Giovanni A, Metafuni E, Laurenti L, Sica S. et al. Hyperleukocytosis and leukostasis: management of a medical emergency. Expert Rev Hematol. 2017;10(2):147–154. doi: 10.1080/17474086.2017.1270754. - DOI - PubMed
1. Siegal T, Benouaich-Amiel A, Bairey O. Neurologic complications of acute myeloid leukemia. Diagnostic approach and therapeutic modalities. Blood Rev. 2022;53:100910. doi: 10.1016/j.blre.2021.100910. - DOI - PubMed
1. Babakhanlou R, Nader ME, Alvarado Y. A case of sudden hearing loss in a patient with chronic myelomonocytic leukemia. Ann Hematol. 2023;102(12):3427–3430. doi: 10.1007/s00277-023-05433-w. - DOI - PubMed